• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Blue Jet Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 77761.0
  • ISIN : INE0KBH01020
816.70 -89 (-9.87%)
  • As on 24 Jul 2025 (EOD)

  • Today’s Low

    815.55

  • Today’s High

    881.40

  • Open

    862.00

  • Perv Close

    906.15

  • 52W Low

    403.40

  • 52W High

    1,027.80

Key Indicators

  • P/E(TTM)

    39.50

  • Mar.Cap (₹Cr.)

    14,166.92

  • Div & Yield %

    0.00

  • Book Value(₹)

    65.32

  • Debt-Equity Ratio

    -9.87

  • AGM Date

    23-Jul-2025

  • EPS

    20.67

  • P/E Ratio

    39.50

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    14,166.92

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    34.69

  • BV (₹)

    65.30

  • Sales( ₹ in Cr.)

    1,029.99

  • NP (in Cr.)

    305.20

  • NP Var(%)

    78.0

  • Div%

    0.0

  • CPS (₹)

    18.60

  • EPS (₹)

    17.60

  • Traded Value (₹ in Lakhs)

    14,162.58

  • 52 Week High

    1,027.80

  • 52 Week Low

    403.40

  • Price BSE

    816.0

  • Price NSE

    817.00

  • Market Capital( in Cr.)

    14,162.58

  • P/C Ratio

    43.80

  • P/E Ratio

    46.40

  • Price Vs.BV

    17.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 711.60 720.98 683.47 498.93 538.20 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 711.60 720.98 683.47 498.93 538.20 -
Other Income 28.86 23.96 19.41 8.61 5.72 -
Stock Adjustments -10.13 14.33 -3.80 44.82 -23.82 -
Total Income 730.33 759.27 699.08 552.36 520.10 -
EXPENDITURE :            
Raw Materials 304.27 350.29 283.65 214.27 186.76 -
Power and Fuel Cost 24.56 32.99 27.25 19.91 19.30 -
Employee Cost 53.19 41.90 33.03 28.96 23.88 -
Other Manufacturing Expenses 33.19 35.44 32.33 31.31 24.99 -
Selling and Administration Expenses 33.50 39.75 43.06 31.91 34.40 -
Miscellaneous Expenses 33.28 15.85 11.08 10.55 11.50 -
Employee Benefit Expenses 53.19 41.90 33.03 28.96 23.88 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 481.98 516.22 430.40 336.91 300.81 -
Operating Profit 248.35 243.05 268.68 215.45 219.29 -
Interest 0.16 1.36 3.30 5.31 7.37 -
Gross Profit 248.19 241.69 265.38 210.14 211.92 -
Depreciation 28.09 25.07 22.15 19.67 18.04 -
Profit Before Tax 220.10 216.62 243.23 190.47 193.88 -
Current Tax 54.20 55.80 62.80 45.90 52.28 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 2.14 0.78 -1.16 2.97 -3.11 -
Reported Net Profit 163.75 160.03 181.59 141.60 144.71 -
Extraordinary Items -7.45 0.57 0.02 3.24 0.23 -
Adjusted Net Profit 171.20 159.46 181.57 138.36 144.48 -
Adjustment below Net Profit -0.01 -0.08 -15.13 0.00 0.13 -
P & L Balance brought forward 646.79 486.85 320.38 178.78 33.94 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 810.53 646.79 486.85 320.38 178.78 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 50.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 1.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 9.44 9.23 10.47 571.54 24,118.67 -
Earnings Per Share(Adj)-Unit Curr 9.44 - - - - -
Book Value 48.73 39.29 30.07 1,371.58 31,483.17 -
Book Value(Adj)-Unit Curr 48.73 - - - - -

Shareholding Pattern

  • Promoter Group

    86.00%

  • Public Share Holding

    14.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 149,180,255 86.00 149,180,255 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 149,180,255 86.00 149,180,255 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,418,507 1.97 3,418,507 53
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 861,907 0.50 861,907 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 773,959 0.45 773,959 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,054,373 2.91 5,054,373 71
2] Non Institution
Bodies Corporate 3,272,016 1.89 3,272,016 445
Clearing Members 591 0.00 591 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 995,084 0.57 995,084 1,675
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 699,744 0.40 699,744 1,565
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 802,068 0.46 802,068 5
Individuals holding nominal share capital up to Rs. 1 lakh 13,134,019 7.57 13,134,019 66,920
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 230 0.00 230 1
Others 0 0.00 0 0
Sub Total 19,230,797 11.09 19,230,797 70,695
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 173,465,425 100.00 173,465,425 70,772

Company Background

Blue Jet Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Blue Jet Healthcare Ltd
  • BSE Code : 77761.0
  • ISIN : INE0KBH01020

  • Incorporation Year

    1968

  • Registered Office

    701,702, 7th Floor Bhumiraj
    Costarica Sect. 18 Navi Mumbai, Thane,
    Maharashtra-400705

  • Telephone

    91-22-6989 1200

  • FAX

  • Chairman

    Akshay Bansarilal Arora:

  • Managing Director

    Shiven Akshay Arora

  • Company Secretary

    Sweta Poddar

  • Auditor

    KKC & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Blue Jet Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Blue Jet Health 816.45 740.46 711.60 39.50 28.55
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,756.92 1,716.29 193.38 32.94
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10